Filing Details

Accession Number:
0001209191-15-043018
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-05-14 21:12:30
Reporting Period:
2015-05-12
Filing Date:
2015-05-14
Accepted Time:
2015-05-14 21:12:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1411158 Anacor Pharmaceuticals Inc. ANAC Pharmaceutical Preparations (2834) 251854385
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1504466 R Kirk Maples C/O Anacor Pharmaceuticals, Inc.
1020 East Meadow Circle
Palo Alto CA 94303
Svp, Program Management No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-05-12 6,060 $6.92 13,880 No 4 M Direct
Common Stock Disposition 2015-05-12 4,900 $60.97 8,980 No 4 S Direct
Common Stock Disposition 2015-05-12 1,160 $61.50 7,820 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2015-05-12 6,060 $0.00 6,060 $6.92
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
12,148 2021-03-31 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.43 to $61.42, inclusive.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.44 to $61.52, inclusive.
  3. This option is fully vested and exercisable.